Coronavirus: Tanzania returnee first Omicron patient in Manipur

The resident of Imphal West district recently returned from the African country via Delhi

omicron
Microscopic view of covid-19 omicron variant or B.1.1.529. 3D rendering
Press Trust of India Imphal
2 min read Last Updated : Dec 27 2021 | 5:57 PM IST

A 48-year-old returnee from Tanzania on Monday tested positive for the Omicron variant of COVID-19 in Manipur, making him the first patient of the strain in the northeastern state, the Directorate of Health Services said.

The resident of Imphal West district recently returned from the African country via Delhi, it said.

The man tested positive for COVID-19 on the eighth day of his return to India, and his sample, which was sent to the Institute of Bioresources and Sustainable Development in Imphal for whole-genome sequencing, was found to be infected with the Omicron strain, the directorate said.

The patient has been placed under isolation at state-run Jawaharlal Nehru Institute of Medical Sciences here, and he has not exhibited any severe symptoms, it said, adding that his temperature, respiratory and pulse rates are being constantly monitored.

Three other family members of the Omicron patient have also tested positive for COVID-19, but their genome sequencing results are yet to come, it added.

Manipur reported 17 new COVID-19 cases on Monday, taking the state's tally to 1,25,723. The northeastern state now has 182 active cases, while 1,23,540 people have recovered from the disease so far, and 2,001 patients have succumbed to the infection to date.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Dec 27 2021 | 5:57 PM IST

Next Story